Gene · 7321
NIH grants1,455
NIH grants whose papers are about the gene, through NIH's grant-paper links.
201 to 220 of 1,455
Download this page as JSON| Grant | Title | UBE2D1 papers | Newest fiscal year |
|---|---|---|---|
| U24HG006673 | Systematic Exploration of the Human Interactome IV | 1 | 2025 |
| U54CA132378 | 1/2 CCNY-MSK Partnership for Cancer Research, Education and Community Outreach | 1 | 2025 |
| U54DK126108 | Cincinnati Cooperative Center of Excellence in Hematology | 1 | 2025 |
| U54MD007602 | Center for Translational Research in Health Disparities | 1 | 2025 |
| UG1CA233338 | ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies | 1 | 2025 |
| ZIAAI000717 | Molecular Mechanisms and Treatment Of Autoimmunity In Humans And Animal Models | 1 | 2025 |
| ZIAAI001125 | Virus-Host Interactions: Induction and Evasion of Host Innate Immunity | 1 | 2025 |
| ZIABC009404 | Regulation of MHC Class II Trafficking in Antigen Presenting Cells | 1 | 2025 |
| ZIABC010313 | Strategies for improving early detection, diagnosis and treatment of liver cancer | 1 | 2025 |
| ZIABC010440 | Protein Structure, Stability, and Amyloid Formation | 1 | 2025 |
| ZIABC010441 | Biomolecular Recognition and Binding Mechanisms | 1 | 2025 |
| ZIABC010547 | Drug Development for Prostate Cancer | 1 | 2025 |
| ZIABC010885 | Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies | 1 | 2025 |
| ZIABC011091 | Cancer Genomics Technology Development | 1 | 2025 |
| ZIABC011304 | Methods for mammalian genetic analysis | 1 | 2025 |
| ZIABC012053 | Developing ACC patient-derived organoids to identify therapeutic vulnerabilities | 1 | 2025 |
| ZIABC012153 | Studying Immune Recognition of Epithelial Cancers Using Organoids | 1 | 2025 |
| ZIADK033008 | Mechanism of protein quality control at the endoplasmic reticulum | 1 | 2025 |
| ZIADK036167 | Structural studies of proteins involved in DNA repair and recombination | 1 | 2025 |
| ZIAES071006 | Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7321/grants?page=11